• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床数据和数字病理学开发并验证用于骨髓增殖性肿瘤形态学评估的深度学习模型。

Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

作者信息

Wang Rong, Shi Zhongxun, Zhang Yuan, Wei Liangmin, Duan Minghui, Xiao Min, Wang Jin, Chen Suning, Wang Qian, Huang Jianyao, Hu Xiaomei, Mei Jinhong, He Jieyu, Chen Feng, Fan Lei, Yang Guanyu, Shen Wenyi, Wei Yongyue, Li Jianyong

机构信息

Department of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Key Laboratory of New Generation Artificial Intelligence Technology and Its Interdisciplinary Applications (Southeast University), Ministry of Education, Nanjing, China.

出版信息

Br J Haematol. 2025 Feb;206(2):596-606. doi: 10.1111/bjh.19938. Epub 2024 Dec 10.

DOI:10.1111/bjh.19938
PMID:39658953
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11829134/
Abstract

The subjectivity of morphological assessment and the overlapping pathological features of different subtypes of myeloproliferative neoplasms (MPNs) make accurate diagnosis challenging. To improve the pathological assessment of MPNs, we developed a diagnosis model (fusion model) based on the combination of bone marrow whole-slide images (deep learning [DL] model) and clinical parameters (clinical model). Thousand and fifty-one MPN and non-MPN patients were divided into the training, internal testing and one internal and two external validation cohorts (the combined validation cohort). In the combined validation cohort, fusion model achieved higher areas under curve (AUCs) than clinical or DL model or both for MPNs and subtype identification. Compared with haematopathologists with different experience, clinical model achieved AUC which was comparable to seniors and higher than juniors (p = 0.0208) for polycythaemia vera. The AUCs of fusion model were comparable to seniors and higher than juniors for essential thrombocytosis (p = 0.0141), prefibrotic primary myelofibrosis (p = 0.0085) and overt primary myelofibrosis (p = 0.0330) identification. In conclusion, the performances of our proposed models are equivalent to senior haematopathologists and better than juniors, providing a new perspective on the utilization of DL algorithms in MPN morphological assessment.

摘要

骨髓增殖性肿瘤(MPN)不同亚型的形态学评估具有主观性,且病理特征存在重叠,这使得准确诊断具有挑战性。为了改进MPN的病理评估,我们基于骨髓全切片图像(深度学习[DL]模型)和临床参数(临床模型)的组合开发了一种诊断模型(融合模型)。1051例MPN和非MPN患者被分为训练组、内部测试组以及一个内部和两个外部验证队列(联合验证队列)。在联合验证队列中,对于MPN及其亚型识别,融合模型的曲线下面积(AUC)高于临床模型或DL模型或两者。与不同经验的血液病理学家相比,临床模型在真性红细胞增多症方面的AUC与资深血液病理学家相当且高于初级血液病理学家(p = 0.0208)。在原发性血小板增多症(p = 0.0141)、纤维化前原发性骨髓纤维化(p = 0.0085)和明显原发性骨髓纤维化(p = 0.0330)的识别中,融合模型的AUC与资深血液病理学家相当且高于初级血液病理学家。总之,我们提出的模型的性能与资深血液病理学家相当且优于初级血液病理学家,为DL算法在MPN形态学评估中的应用提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/33f385e97661/BJH-206-596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/89d5ee05c9d5/BJH-206-596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/32ee4a31501a/BJH-206-596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/8c2d93f6f3ce/BJH-206-596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/3096cac99c23/BJH-206-596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/33f385e97661/BJH-206-596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/89d5ee05c9d5/BJH-206-596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/32ee4a31501a/BJH-206-596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/8c2d93f6f3ce/BJH-206-596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/3096cac99c23/BJH-206-596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b87c/11829134/33f385e97661/BJH-206-596-g004.jpg

相似文献

1
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.利用临床数据和数字病理学开发并验证用于骨髓增殖性肿瘤形态学评估的深度学习模型。
Br J Haematol. 2025 Feb;206(2):596-606. doi: 10.1111/bjh.19938. Epub 2024 Dec 10.
2
Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.SF3B1 突变型骨髓增殖性肿瘤的临床病理和分子特征。
Hum Pathol. 2019 Apr;86:1-11. doi: 10.1016/j.humpath.2018.11.022. Epub 2018 Dec 27.
3
Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges.印度 BCR/ABL1 阴性骨髓增殖性肿瘤患者的临床和分子特征:真实世界数据和挑战。
Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):e569-e578. doi: 10.1016/j.clml.2021.01.017. Epub 2021 Feb 23.
4
Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders--a clue to diagnosis and classification.慢性骨髓增殖性疾病骨髓活检的临床病理学与组织化学——诊断与分类的线索
Pathol Biol (Paris). 2001 Mar;49(2):140-7. doi: 10.1016/s0369-8114(00)00019-5.
5
WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes.世界卫生组织(WHO)髓系增殖性肿瘤的组织学标准:可重复性、诊断准确性及其与基因突变和临床结果的相关性。
Br J Haematol. 2014 Sep;166(6):911-9. doi: 10.1111/bjh.12990. Epub 2014 Jun 24.
6
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.与内脏静脉血栓形成相关的BCR-ABL1阴性骨髓增殖性肿瘤中骨髓组织病理学与临床表型之间的差异。
Leuk Res. 2015 May;39(5):525-9. doi: 10.1016/j.leukres.2015.03.009. Epub 2015 Mar 19.
7
[The unclassifiable myeloproliferative neoplasm--morphological, cytogenetic and clinical features].[无法分类的骨髓增殖性肿瘤——形态学、细胞遗传学及临床特征]
Acta Med Croatica. 2011 Sep;65 Suppl 1:31-6.
8
Myeloproliferative neoplasms: Morphology and clinical practice.骨髓增殖性肿瘤:形态学与临床实践。
Am J Hematol. 2016 Jun;91(4):430-3. doi: 10.1002/ajh.24288.
9
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.脑静脉血栓形成与骨髓增殖性肿瘤:来自两个大型数据库的结果
Thromb Res. 2014 Jul;134(1):41-3. doi: 10.1016/j.thromres.2014.03.040. Epub 2014 Mar 29.
10
Constructing a Deep Learning Radiomics Model Based on X-ray Images and Clinical Data for Predicting and Distinguishing Acute and Chronic Osteoporotic Vertebral Fractures: A Multicenter Study.基于 X 射线图像和临床数据构建深度学习放射组学模型预测和区分急性和慢性骨质疏松性椎体骨折:一项多中心研究。
Acad Radiol. 2024 May;31(5):2011-2026. doi: 10.1016/j.acra.2023.10.061. Epub 2023 Nov 27.

引用本文的文献

1
A Dual-Feature Framework for Enhanced Diagnosis of Myeloproliferative Neoplasm Subtypes Using Artificial Intelligence.一种使用人工智能增强骨髓增殖性肿瘤亚型诊断的双特征框架。
Bioengineering (Basel). 2025 Jun 7;12(6):623. doi: 10.3390/bioengineering12060623.
2
Beyond Biomarkers: Machine Learning-Driven Multiomics for Personalized Medicine in Gastric Cancer.超越生物标志物:机器学习驱动的多组学在胃癌个性化医疗中的应用
J Pers Med. 2025 Apr 24;15(5):166. doi: 10.3390/jpm15050166.
3
Research trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis.

本文引用的文献

1
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives.骨髓纤维化样巨核细胞发育异常(MTMD)作为 BCR::ABL 阴性骨髓增殖性肿瘤的一个独特类别。挑战与展望。
Leukemia. 2023 Apr;37(4):725-727. doi: 10.1038/s41375-023-01861-9. Epub 2023 Mar 4.
2
Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management.原发性骨髓纤维化:2023年诊断、风险分层及管理的最新进展
Am J Hematol. 2023 May;98(5):801-821. doi: 10.1002/ajh.26857. Epub 2023 Feb 6.
3
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.
2001年至2024年原发性血小板增多症的研究趋势:一项文献计量分析
Discov Oncol. 2025 Apr 15;16(1):528. doi: 10.1007/s12672-025-02232-9.
纤维化的持续指数化(CIF):改善 MPN 患者的评估和分类。
Leukemia. 2023 Feb;37(2):348-358. doi: 10.1038/s41375-022-01773-0. Epub 2022 Dec 5.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
5
Deep learning-based histopathological segmentation for whole slide images of colorectal cancer in a compressed domain.基于深度学习的结直肠癌全切片图像在压缩域中的病理分割。
Sci Rep. 2021 Nov 18;11(1):22520. doi: 10.1038/s41598-021-01905-z.
6
How artificial intelligence might disrupt diagnostics in hematology in the near future.人工智能在不远的将来可能如何颠覆血液学诊断
Oncogene. 2021 Jun;40(25):4271-4280. doi: 10.1038/s41388-021-01861-y. Epub 2021 Jun 8.
7
Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies.人工智能在诊断不确定的前列腺活检中提前申请免疫组织化学检测。
Mod Pathol. 2021 Sep;34(9):1780-1794. doi: 10.1038/s41379-021-00826-6. Epub 2021 May 20.
8
Generative Deep Learning in Digital Pathology Workflows.生成式深度学习在数字病理学工作流程中的应用。
Am J Pathol. 2021 Oct;191(10):1717-1723. doi: 10.1016/j.ajpath.2021.02.024. Epub 2021 Apr 8.
9
The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer.人工智能检测睾丸癌中淋巴管侵犯的潜力。
Cancers (Basel). 2021 Mar 16;13(6):1325. doi: 10.3390/cancers13061325.
10
[Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations].[骨髓增殖性肿瘤中巨核细胞的病理特征及其与驱动基因突变的相关性]
Zhonghua Xue Ye Xue Za Zhi. 2020 Oct 14;41(10):798-805. doi: 10.3760/cma.j.issn.0253-2727.2020.10.002.